Background: We have previously shown that lipopolysaccharide (LPS) exposure in sensitised animals 18 h after ovalbumin (OVA) challenge inhibits OVA-induced airway hyper-responsiveness (AHR). In the present study, we investigated the effect of LPS on OVA-induced acute and late-phase allergic responses in sensitised rats when challenged with OVA. Methods: Rats were sensitised with OVA and 11 days later challenged with 1% OVA in the presence or absence of LPS (0.5–50 µg/ml) given in the same nebulizer. Acute responses to OVA were measured each minute for 30 min after challenge. In a separate group of animals, late-phase responses to OVA were determined at 24 h. At the end of each study, Evans blue dye was injected and animals sacrificed 30 min later. Bronchoalveolar lavage was obtained to monitor inflammatory cell migration and microvascular leakage. Results: OVA challenge in sensitised animals produced an acute response with changes in lung mechanics peaking 10.0 ± 0.9 min after OVA and returning to baseline within 30 min. This was followed 24 h later by increased responses to methacholine chloride (MCh), inflammatory cell influx and increased Evans blue leakage into the lungs. Presence of 5 or 50 µg/ml LPS in the nebulizer during OVA challenge altered the kinetics of the acute-phase response, with an immediate decrease in lung function (time to peak decreased from 10.3 ± 1.2 to 1.8 ± 0.2 and 2.2 ± 0.3 min, respectively: p < 0.001, n = 6) and a dose-dependent attenuation of late-phase AHR, cellular influx (n = 5, p < 0.001) and Evans blue leakage (n = 5, p < 0.001) at 24 h. Conclusions: In summary, co-administration of OVA with LPS modifies both the acute and late-phase responses to the allergen, inducing an earlier acute change in lung function and a dose-dependent inhibition of late-phase responses to the allergen.

1.
Martinez FD: Role of viral infections in the inception of asthma and allergies during childhood: Could they be protective? (review). Thorax 1994;40:1189–1191.
2.
Strachan DP: Hay fever, hygiene, and household size. BMJ 1989;299:1259–1260.
3.
Holt PG, Sly PD, Bjorksten B: Atopic versus infectious diseases in childhood: A question of balance? Pediatr Allergy Immunol 1997;8:53–58.
4.
Holt PG, Macaubas C: Development of long-term tolerance versus sensitisation to environmental allergens during the perinatal period (review). Curr Opin Immunol 1997;9:782–787.
5.
Michel O, Duchateau J, Sergysels R: Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989;66:1059–1064.
6.
Olenchock SA, May JJ, Pratt DS, Morey PR: Occupational exposures to airborne endotoxins in agriculture. Prog Clin Biol Res 1987;231:475–487.
7.
Michel O, Ginanni R, Le Bon B, Content J, Duchateau J, Sergysels R: Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis 1992;146:352–357.
8.
Rylander R, Bake B, Fischer JJ, Helander IM: Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989;140:981–986.
9.
Michel O, Ginanni R, Duchateau J, Vertongen F, Le Bon B, Sergysels R: Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy 1991;21:441–448.
10.
Hunt LW, Gleich GJ, Ohnishi T, Weiler DA, Mansfield ES, Kita H, Sur S: Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am J Respir Crit Care Med 1994;149:1471–1475.
11.
Tulic MK, Wale JL, Holt PG, Sly PD: Modification of the inflammatory response to allergen challenge following exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000;22:604–612.
12.
Peták F, Hantos Z, Adamicza Á, Asztalos T, Sly PD: Methacholine-induced bronchoconstriction in rats: Effects of intravenous vs. aerosol delivery. J Appl Physiol 1997;82:1479–1487.
13.
Van Halteren AGS, Van Der Cammen MJF, Biewenga J, Savelkoul HFJ, Kraal G: IgE and mast cell responses on intestinal allergen exposure: A murine model to study the onset of food allergy. J Allergy Clin Immunol 1997;99:94–99.
14.
Thompson-Snipes LA, Dhar V, Bond MW, Mossman TR, Moore KW, Rennick DM: Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991;173:507–510.
15.
Welker P, Grabbe J, Zuberbier T, Guhl S, Henz BM: Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol 2000;114:44–50.
16.
Li Y, Nguyen TD, Stechschulte AC, Stechschulte DJ, Dileepan KN: Effect of mast cell granules on the gene expression of nitric oxide synthase and tumour necrosis factor-alpha in macrophages. Mediators Inflamm 1998;7:355–361.
17.
Rylander R, Holt PG: (1→3)-beta-D-glucan and endotoxin modulate immune response to inhaled allergen. Mediators Inflammm 1998;7:105–110.
18.
Mosmann T, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138–146.
19.
Woolley MJ, Woolley KL, Otis J, Conlon PD, O’Byrne PM, Jordana M: Inhibitory effects of IL-10 on allergen-induced airway inflammation and airway responses in Brown Norway rats. Am J Respir Crit Care Med 1994;149:A760.
20.
Tournoy KG, Kips JC, Pauwels RA: Endogenous interleukin-10 suppresses allergen-induced airway inflammation and non-specific airway responsiveness. Clin Exp Allergy 2000;30:775–783.
21.
Tulic MK, Knight DA, Holt PG, Sly PD: Lipopolysaccharide inhibits the late-phase response to allergen by altering nitric oxide synthase activity and IL-10. Am J Respir Cell Mol Biol 2001;24:640–646.
22.
de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915–924.
23.
Holt PG, Macaubas C, Stumbles PA, Sly PD: The role of allergy in the development of asthma. Nature 1999;402:B12–B17.
24.
Martinez FD, Holt PG: Role of microbial burden in aetiology of allergy and asthma (review). Lancet 1999;354:S1112–S1115.
25.
Corne J, Smith S, Schreiber J, Holgate ST: Prevalence of atopy in asthma. Lancet 1994;344:344–345.
26.
Carvalheiro MF, Peterson Y, Rubenowitz E, Rylander R: Bronchial reactivity and work-related symptoms in farmers. Am J Indust Med 1995;27:65–74.
27.
Schwartz DA, Donham KJ, Olenchock SA, Popendorf WJ, Van Fossen DS, Burmeister LF, Merchant JA: Determinants of longitudinal changes in spirometric function among swine confinement operators and farmers. Am J Respir Crit Care Med 1995;151:47–53.
28.
Rylander R: Endotoxins in the environment; in Levin J, Alving CR, Munford RS, Redl H (eds): Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy. New York, Wiley-Liss, 1994, pp 79–90.
29.
Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O, von Kries R: Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000;30:187–193.
30.
Riedler J, Eder W, Oberfeld G, Schreuer M: Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000;30:194–200.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.